SAR by MS: Discovery of a New Class of RNA-Binding Small Molecules for the Hepatitis C Virus: Internal Ribosome Entry Site IIA Subdomain
Journal of Medicinal Chemistry2005Vol. 48(23), pp. 7099–7102
Citations Over TimeTop 10% of 2005 papers
Punit P. Seth, Alycia Miyaji, Elizabeth A. Jefferson, Kristin A. Sannes‐Lowery, Stephen A. Osgood, Stephanie Propp, Ray Ranken, Christian Massire, Rangarajan Sampath, David J. Ecker, Eric E. Swayze, Richard H. Griffey
Abstract
A new class of small molecules that bind the HCV RNA IRES IIA subdomain with sub-micromolar affinity is reported. The benzimidazole 'hit' 1 with a KD approximately 100 microM to a 29-mer RNA model of Domain IIA was identified from a 180000-member library using mass spectrometry-based screening methods. Further MS-assisted SAR (structure-activity relationships) studies afforded benzimidazole derivatives with sub-micromolar binding affinity for the IIA RNA construct. The optimized benzimidazoles demonstrated activity in a cellular replicon assay at concentrations comparable to their KD for the RNA target.
Related Papers
- → A search for structurally similar cellular internal ribosome entry sites(2007)85 cited
- → High‐efficiency protein expression mediated by enterovirus 71 internal ribosome entry site(2005)21 cited
- → Characterization of a replicon of the moderately promiscuous plasmid, pGSH5000, with features of both the mini‐replicon of pCU1 and the ori‐2 of F(1993)13 cited
- 원저 ( Original Articles ) ; SV40 전이 포유동물세포에 있어 복제기구의 크기와 자외선 감수성(1982)
- → Benzimidazole(2003)